{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,30]],"date-time":"2026-03-30T08:21:29Z","timestamp":1774858889924,"version":"3.50.1"},"reference-count":22,"publisher":"Informa UK Limited","issue":"1","funder":[{"name":"BeOne Medicines"}],"content-domain":{"domain":["www.tandfonline.com"],"crossmark-restriction":true},"short-container-title":["Current Medical Research and Opinion"],"published-print":{"date-parts":[[2026,1,2]]},"DOI":"10.1080\/03007995.2026.2623629","type":"journal-article","created":{"date-parts":[[2026,2,13]],"date-time":"2026-02-13T14:33:16Z","timestamp":1770993196000},"page":"139-146","update-policy":"https:\/\/doi.org\/10.1080\/tandf_crossmark_01","source":"Crossref","is-referenced-by-count":0,"title":["Zanubrutinib versus ibrutinib in patients with relapsed\/refractory chronic lymphocytic leukemia and small lymphocytic lymphoma: health-related quality of life in a subgroup of Chinese patients in the ALPINE trial"],"prefix":"10.1080","volume":"42","author":[{"given":"Constantine S.","family":"Tam","sequence":"first","affiliation":[{"name":"Department of Haematology, Alfred Health","place":["Melbourne, Australia"]},{"name":"Central Clinical School, Monash University","place":["Melbourne, Australia"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mazyar","family":"Shadman","sequence":"additional","affiliation":[{"name":"Clinical Research Division, Fred Hutchinson Cancer Research Center","place":["Seattle, USA"]},{"name":"Division of Hematology and Oncology, University of Washington","place":["Seattle, USA"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shin Yeu","family":"Ong","sequence":"additional","affiliation":[{"name":"Department of Haematology, Singapore General Hospital","place":["Singapore, Singapore"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ken","family":"Wu","sequence":"additional","affiliation":[{"name":"BeOne Medicines Ltd.","place":["San Carlos, USA"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tommi","family":"Salmi","sequence":"additional","affiliation":[{"name":"BeOne Medicines Ltd., GmbH","place":["Basel, Switzerland"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rasika","family":"Korde","sequence":"additional","affiliation":[{"name":"BeOne Medicines Ltd.","place":["San Carlos, USA"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gisoo","family":"Barnes","sequence":"additional","affiliation":[{"name":"BeOne Medicines Ltd.","place":["San Carlos, USA"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jennifer R.","family":"Brown","sequence":"additional","affiliation":[{"name":"Department of Medical Oncology, Dana-Farber Cancer Institute","place":["Boston, USA"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Keshu","family":"Zhou","sequence":"additional","affiliation":[{"name":"Department of Hematology, Henan Cancer Hospital","place":["Zhengzhou, China"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lugui","family":"Qiu","sequence":"additional","affiliation":[{"name":"State Key Laboratory of Experimental Hematology, National Clinical Research Center for Blood Diseases, Institute of Hematology and Blood Diseases Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College (PUMC)","place":["Tianjin, China"]}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"301","published-online":{"date-parts":[[2026,2,13]]},"reference":[{"key":"#cr-split#-e_1_3_5_2_1.1","unstructured":"American Cancer Society. Types of B-cell lymphoma [updated 2024 Feb 15"},{"key":"#cr-split#-e_1_3_5_2_1.2","unstructured":"cited 2024 Nov 26]. Available from: https:\/\/www.cancer.org\/cancer\/types\/non-hodgkin-lymphoma\/about\/b-cell-lymphoma.html"},{"key":"e_1_3_5_3_1","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2022.840616"},{"key":"e_1_3_5_4_1","unstructured":"BeiGene. Brukinsa\u00ae (zanubrutinib). US Healthcare Professionals. [cited 2024 Nov 26]. Available from: https:\/\/www.brukinsa.com\/hcp\/"},{"key":"e_1_3_5_5_1","unstructured":"BeiGene. BeiGene receives new approvals for Brukinsa\u00ae (zanubrutinib) in China. Press release [updated 20203 May 26; cited 2024 Nov 26]. Available from: https:\/\/ir.beigene.com\/news\/beigene-receives-new-approvals-for-brukinsa-zanubrutinib-in-china\/7e5cd979-7835-4263-8dde-f426c721fb3e\/"},{"key":"e_1_3_5_6_1","doi-asserted-by":"publisher","DOI":"10.1016\/S1470-2045(22)00293-5"},{"key":"e_1_3_5_7_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa2211582"},{"key":"e_1_3_5_8_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood.2024024667"},{"key":"e_1_3_5_9_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO-24-02265"},{"key":"e_1_3_5_10_1","doi-asserted-by":"publisher","DOI":"10.1080\/03007995.2023.2262378"},{"key":"e_1_3_5_11_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00277-024-05823-8"},{"key":"e_1_3_5_12_1","doi-asserted-by":"publisher","DOI":"10.2217\/fon-2019-0844"},{"key":"e_1_3_5_13_1","doi-asserted-by":"publisher","DOI":"10.1093\/jnci\/85.5.365"},{"key":"e_1_3_5_14_1","doi-asserted-by":"publisher","DOI":"10.1007\/s11136-011-9903-x"},{"key":"e_1_3_5_15_1","doi-asserted-by":"publisher","DOI":"10.1007\/s11136-015-1039-y"},{"key":"e_1_3_5_16_1","doi-asserted-by":"publisher","DOI":"10.1007\/978-3-642-83419-6_27"},{"key":"e_1_3_5_17_1","doi-asserted-by":"publisher","DOI":"10.1007\/BF00439229"},{"key":"e_1_3_5_18_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.1998.16.1.139"},{"key":"e_1_3_5_19_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1524-4733.2007.00273.x"},{"key":"e_1_3_5_20_1","doi-asserted-by":"publisher","DOI":"10.1200\/GO.22.00266"},{"key":"e_1_3_5_21_1","doi-asserted-by":"publisher","DOI":"10.1038\/bjc.2016.158"},{"key":"e_1_3_5_22_1","doi-asserted-by":"publisher","DOI":"10.1111\/cts.12948"}],"container-title":["Current Medical Research and Opinion"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.tandfonline.com\/doi\/pdf\/10.1080\/03007995.2026.2623629","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,3,30]],"date-time":"2026-03-30T07:37:42Z","timestamp":1774856262000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.tandfonline.com\/doi\/full\/10.1080\/03007995.2026.2623629"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1,2]]},"references-count":22,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2026,1,2]]}},"alternative-id":["10.1080\/03007995.2026.2623629"],"URL":"https:\/\/doi.org\/10.1080\/03007995.2026.2623629","relation":{},"ISSN":["0300-7995","1473-4877"],"issn-type":[{"value":"0300-7995","type":"print"},{"value":"1473-4877","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,1,2]]},"assertion":[{"value":"The publishing and review policy for this title is described in its Aims & Scope.","order":1,"name":"peerreview_statement","label":"Peer Review Statement"},{"value":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=icmo20","URL":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=icmo20","order":2,"name":"aims_and_scope_url","label":"Aim & Scope"},{"value":"2025-11-17","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2026-01-21","order":1,"name":"revised","label":"Revised","group":{"name":"publication_history","label":"Publication History"}},{"value":"2026-01-25","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2026-02-13","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}